Published in
American Association for the Advancement of Science, Science Translational Medicine, 615(13), 2021
DOI: 10.1126/scitranslmed.abf7860
Links
Tools
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas
Journal article published in 2021 by
Stefan R. Sweha 
,
Chan Chung ,
Siva Kumar Natarajan ,
Pooja Panwalkar ,
Matthew Pun ,
Amer Ghali ,
Jill Bayliss ,
Drew Pratt ,
Anand Shankar,
Visweswaran Ravikumar ,
Arvind Rao ,
Marcin Cieslik,
Kari Wilder-Romans,
Andrew J. Scott ,
Daniel R. Wahl
and other authors.
,
Chan Chung ,
Siva Kumar Natarajan ,
Pooja Panwalkar ,
Matthew Pun ,
Amer Ghali ,
Jill Bayliss ,
Drew Pratt ,
Anand Shankar,
Visweswaran Ravikumar ,
Arvind Rao ,
Marcin Cieslik,
Kari Wilder-Romans,
Andrew J. Scott ,
Daniel R. Wahl
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Histone H3.3G34R/V mutant gliomas demonstrate LIF/STAT pathway activation that can be disrupted for therapeutic benefit.